The FDA approves the first generic versions of Singulair for use in adults and children to...

|By:, SA News Editor

The FDA approves the first generic versions of Singulair for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies. Endo Pharmaceuticals (ENDP +3.2%), Mylan (MYL +4.2%) and Teva Pharmaceuticals (TEVA -0.6%) have all been given the go-ahead.